LEP and Cachexia: Given the key role that inflammation appears to play in the pathogenesis of leptin-mediated cachexia, therapeutic intervention with anti-inflammatory drugs may prove to be beneficial in restoring sensitivity to the effect of hypoleptinemia in ACS.